-
Intermountain expands central lab to reduce testing costs
Intermountain Health's central lab in Murray, Utah, has expanded and nearly doubled in size to help lower testing costs and improve lab services for patients and the system's hospitals in the region. -
FDA finalizes rule to regulate hospital lab tests
The FDA finalized a rule April 29 to treat laboratory-developed tests as medical devices, putting them in the purview of federal oversight. -
New York research institute to build lab
Utica, N.Y.-based Masonic Medical Research Institute is proposing to build a 32,000-square-foot laboratory in East Utica, the Utica Observer-Dispatch reported Jan. 11. -
Rhode Island Primary Care Physicians Corp. teams up with Akido Labs
Rhode Island Primary Care Physicians Corp., the biggest physician-led healthcare organization in the state of Rhode Island, recently announced a joint venture with Akido Labs, a leader in AI, safety-net and population management programs. -
Researchers discover 35 new bacteria in patient samples
University of Basel (Switzerland) and University Hospital Basel researchers discovered 35 unknown bacterial pathogens in blood or tissue samples, including seven that caused clinical infections. -
Abbott's clinical lab automation solution gets FDA approval
A new automation system from Abbott, designed to improve workflows in clinical lab settings, has been granted FDA approval. -
AHA urges FDA not to move forward with proposed rule to regulate lab tests
The American Hospital Association is urging the FDA not to move forward with a proposed rule to treat laboratory-developed tests as medical devices, saying the move would disrupt innovation and potentially increase hospital costs. -
Viewpoint: Hospitals should expand drug urinalysis
Standard hospital urine drug analyses do not test for current popular drugs that lead to fatal overdoses, leading to missing diagnoses, according to an opinion piece published Nov. 15 in Scientific American. -
Northwell debuts single test for tripledemic viruses as RSV ramps up
New Hyde Park, N.Y.-based Northwell Health has unveiled a three-in-one swab to test for COVID-19, flu and respiratory syncytial virus. -
Hackensack Meridian launches diagnostics company
Hackensack Meridian Health is spinning off its first company based on science from its research institute, the Edison, N.J.-based system said Oct. 4. -
Quest Diagnostics earns FDA breakthrough designation for adeno-associated virus test
Quest Diagnostics was recently granted a breakthrough device designation from the FDA for its adeno-associated virus test. -
What CDC lab functions could look like under new center proposal
The CDC could restructure its lab operations under recent recommendations made by its Laboratory Workgroup. -
CDC to overhaul lab operations in wake of COVID failures
The CDC plans to overhaul its lab operations after mishaps with its COVID-19 test, KFF Health News reported Aug. 21. -
Orlando Health labs earn College of American Pathologists accreditation
Three of Orlando (Fla.) Health's laboratories recently received accreditation from the College of American Pathologists. -
NewYork-Presbyterian sells lab assets for $275M
Quest Diagnostics acquired assets from NewYork-Presbyterian' lab business in an all-cash transaction for $275 million, according to financial documents filed July 27 with the Securities and Exchange Commission. -
Multiple labs, owner charged in alleged scheme to profit from unnecessary testing
The Justice Department filed a complaint against Patrick Britton-Harr and several laboratory companies he owns for allegedly submitting claims to Medicare for tests that were not ordered by providers, not medically necessary and sometimes never performed. -
Scientist behind 'CRISPR babies' is back in the lab
He Jiankui, PhD, a Chinese scientist who sparked controversy in 2018 after claiming to have genetically modified two human embryos, is on a new scientific endeavor: trying to develop a therapy for Duchenne muscular dystrophy, NPR reported June 8. -
FDA greenlights at-home combo test for flu, COVID-19
On Feb. 24, the FDA issued an emergency use authorization for the first over-the-counter rapid test that can detect both COVID-19 and flu. However, it's unclear when the test might be available to consumers as Lucira Health, the test's developer, faces financial challenges, according to Politico. -
Quest to acquire nonhospital-based labs from NewYork-Presbyterian
Quest Diagnostics has agreed to acquire some laboratory services assets from New York City-based NewYork-Presbyterian. -
Rapid COVID test developed by engineers is 1,000 times more sensitive than others
A team of engineers and infectious disease researchers at Washington University in St. Louis developed a new rapid point-of-care diagnostic test that is 1,000 times more sensitive than conventional tests.
Page 1 of 50